Recruiting
Phase 2

Observational Study

Sponsor:

University of Alberta

Code:

NCT06570473

Conditions

Pulmonary Hypertension

Right Ventricular Dysfunction

Right Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Empagliflozin

Ranolazine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by University of Alberta on 2025-09-18.